Asthma is one of the most common noncommunicable diseases, raising serious concerns about asthma-related deaths globally. Studies have reported safety concerns with shortacting beta-agonists (SABAs) monotherapy. SABA overuse contributes significantly to the healthcare burden in the Philippines. Despite Global Asthma Network's years-long advocacy for equal access to good quality essential medicines at an affordable cost, the uptake of international healthcare policies is limited in most low- and middle-income countries, including the Philippines. We reviewed a synthesis of targeted nonsystematic literature searches on the prevalence of asthma and asthma-related mortality, SABA overreliance and its adverse events, alternatives to SABA, patient referral, and the MDT approach for asthma management. Here, we describe regional challenges and recommendations for improving asthma care through continued multisectoral collaboration. The use of medications like inhaled corticosteroidformoterol combinations may aid in reducing adverse events including severe exacerbations, hospitalizations, complications resulting from oral corticosteroid use, and longterm treatment costs. Raising patient awareness about preventive measures, proper inhaler technique, and medication adherence can mitigate the burden of uncontrolled asthma. In addition, improving access to asthma medications, developing treatment algorithms and referral pathways including a multidisciplinary team for primary care physicians will pave the way for optimal asthma care in LMICs including the Philippines.
Read full abstract